PALO ALTO, Calif., June 29, 2017 /PRNewswire/ -- Varian Medical
Systems (NYSE: VAR) has received FDA 510(k) clearance for its
Halcyon™ system, its new device for cancer treatment.
Halcyon simplifies and enhances virtually every aspect of
image-guided volumetric intensity modulated radiotherapy
(IMRT).
"We are proud that Halcyon has now received both 510(k)
clearance and CE mark," said Kolleen
Kennedy, president of Varian's Oncology Systems business.
"With its human-centered and user-friendly design, Halcyon is
engineered to revolutionize clinical workflow. These two clearances
are very important milestones in the availability of this new
system and advancing cost-effective cancer care worldwide."
Halcyon is an advanced system that is more comfortable for the
patient while delivering ease of use for healthcare providers,
accelerated installation timeframes, expedited commissioning,
simplified training, and automated treatment. With its streamlined
workflow, the system only requires nine steps from the start to the
end of treatment compared to up to more than 30 steps with older
technologies. Halcyon is well suited to handle the majority of
cancer patients, offering advanced treatments for prostate, breast,
head & neck, and many other forms of cancer.
Halcyon features large touchscreens on both sides of the machine
to assist in easy patient set-up. For increased patient comfort,
Halcyon is up to 2x quieter than other systems, has a low couch
height for easy patient access, and soft indirect ambient lighting
in the gantry opening. To create a closer connection between
patient and therapist during Halcyon treatment, the system includes
an integrated couch-mounted camera for the therapist to watch over
the patient during treatment, and an integrated noise-cancelling
sound system that makes it easy for patients to converse with the
therapists.
With 510(k) clearance, Varian can begin selling the Halcyon
system in the United States. The
system requires Eclipse™ 15.1.1 treatment planning
software, which is currently 510(k) pending. For more information
on Halcyon visit www.varian.com/halcyon.
About Varian Medical Systems
Varian Medical Systems focuses energy on saving lives and is the
world's leading manufacturer of medical devices and software for
treating and managing cancer. Headquartered in Palo Alto, California, Varian employs
approximately 6,400 people around the world. For more
information, visit http://www.varian.com and follow @VarianMedSys
on Twitter.
Press Contact
Mark Plungy
Varian Medical Systems
+1 (650) 424-5630
mark.plungy@varian.com
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/varian-medical-systems-receives-fda-510k-clearance-for-halcyon-treatment-system-300481584.html
SOURCE Varian Medical Systems